News round-up for 8-12 September by DDW Editor Reece Armstrong.

Fast-track designations by the FDA, clinical trials to advance mental health and pharma team-ups to bring innovations to market are just some of the stories in this week’s news round-up.

The top stories

FDA fast-tracks Sanofi’s AMD gene therapy

Sanofi’s investigational one-time intravitreal gene therapy for the treatment of neovascular age-related macular degeneration (AMD) has been granted fast track designation by the US Food and Drug Administration (FDA).

Read more

First NHS-embedded clinical trial site for mental health launches

The UK’s first fully NHS-embedded commercial research for brain and mental health conditions has been launched by Clerkenwell Health.

Read more

Pioneer and AbbVie team up on a Golden Ticket to accelerate human health 

Pioneer Group, a specialist in life science infrastructure and venture building, has again teamed up with biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and hepatology.

Read more

MoU signed to advance precision medicine growth in Serbia 

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (BIO4), the Republic of Serbia’s flagship biotechnology and life sciences hub, have announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.

Read more

New NICE thresholds is good news for ultra-rare disease drugs, says biotech 

The National Institute for Health and Care Excellence (NICE), the body that determines the clinical effectiveness and economic value of new medicines, has increased the cost-effectiveness thresholds it applies for drugs that qualify for their Highly Specialised Technology (HST) programme.

Read more